3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Amyloidosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyreuther, K; Czech, C; De Strooper, B; Dotti, CG; Hartmann, T; Ida, N; Ikonen, E; Masters, CL; Multhaup, G; Simons, M; Tienari, PJ; Van Leuven, F; Weidemann, A | 1 |
1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Amyloidosis
Article | Year |
---|---|
The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Axonal Transport; Axons; Cell Membrane; Cell Polarity; Cells, Cultured; Cholic Acids; Detergents; Epitopes; Glycosylation; Hemagglutinins, Viral; Hippocampus; Humans; Molecular Sequence Data; Neurons; Proto-Oncogene Proteins c-myc; Rats; Recombinant Fusion Proteins; Semliki forest virus; Sequence Deletion; Solubility; Tunicamycin | 1996 |